- €151.08m
- €204.86m
- €211.48m
- 70
- 71
- 54
- 74
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 217 | 267 | 249 | 229 | 211 |
Cost of Revenue | |||||
Gross Profit | 66 | 86.8 | 77.2 | 74.7 | 86.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 210 | 249 | 236 | 210 | 191 |
Operating Profit | 7.75 | 18.3 | 13 | 18.2 | 20.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.25 | 22.4 | 8.1 | 14.4 | 15.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.59 | 21.4 | 6.68 | 12.7 | 14.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.31 | 23.5 | 6.3 | 11.3 | 13.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.31 | 23.5 | 6.3 | 11.3 | 13.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.019 | 0.378 | 0.037 | 0.157 | 0.271 |
Dividends per Share |